Since the first description of Philadelphia chromosome-negative
chronic myeloproliferative disorders more than 100 years ago, the
diagnosis and therapy of these conditions have been based primarily
on clinical experience and judgement. Until recently very little
was known about the molecular basis of these diseases. In order to
spark research in this area basic scientists and clinicians from
various parts of the world have contributed to this volume, the
first of its kind to put together the current knowledge. The book
deals with the new WHO classification of these disorders, novel
aspects of diagnostic pathology, the search for disease-relevant
genes utilizing molecular biology and proteomic techniques, the
description of the roles of PVR-1 and VHL genes for polycythemias
and the discovery of the gene mutation responsible for the
idiopathic hypereosinophilic syndrome. A chapter on anagrelide, an
important novel drug for the treatment of primary thrombocythemia,
is included.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!